Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice

NCT ID: NCT03453567

Last Updated: 2024-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

900 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-05-10

Study Completion Date

2030-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluated effectiveness and safety of aortic valve replacement in real-world clinical practice.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Valve Disease Aortic Valve Stenosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

TAVR SAVR TAVI Conventional AVR Sutureless AVR

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TAVR

Transcatheter Aortic Valve Replacement

Valve Replacement

Intervention Type PROCEDURE

Aortic valve replacement

Sutureless AVR

Sutureless Aortic Valve Replacement

Valve Replacement

Intervention Type PROCEDURE

Aortic valve replacement

Conventional AVR

Conventional Aortic Valve Replacement

Valve Replacement

Intervention Type PROCEDURE

Aortic valve replacement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Valve Replacement

Aortic valve replacement

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 19 and more
* Patient with aortic valve replacement

Exclusion Criteria

* Combined with mitral stenosis requiring surgery or aorta stenosis
* Acute bacterial endocarditis within 1 month of valve replacement
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

CardioVascular Research Foundation, Korea

OTHER

Sponsor Role collaborator

Seung-Jung Park

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Seung-Jung Park

Professor, Division of Cardiology

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Suk-Jung Choo, MD

Role: PRINCIPAL_INVESTIGATOR

Asan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sejong Hospital

Bucheon-si, , South Korea

Site Status

Asan Medical Center

Seoul, , South Korea

Site Status

Pusan National University Yangsan Hospital

Yangsan, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AMCCV2018-04

Identifier Type: -

Identifier Source: org_study_id